# Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

> **NCT01023841** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 71 (actual)

## Conditions studied

- Eyelash Hypotrichosis
- Alopecia Areata

## Interventions

- **DRUG:** bimatoprost ophthalmic solution 0.03%
- **DRUG:** Vehicle Sterile Solution

## Key facts

- **NCT ID:** NCT01023841
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-01
- **Primary completion:** 2012-11-02
- **Final completion:** 2012-11-30
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2019-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023841, "Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01023841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*